News Website

Feasibility of Percutaneous Radiofrequency Ablation for Abdominal Wall Endometriosis: A Prospective Pilot Study.

To assess the feasibility of percutaneous radiofrequency ablation (PRFA) of anterior abdominal wall endometriosis (AWE) lesions and to describe its efficacy on clinical symptoms and on the volume of the …

Published: Oct. 25, 2024, midnight

Read Full Article

abdominal wall endometriosis extra pelvic endometriosis percutaneous radiofrequency ablation

Hollyoaks star shares how she copes with painful illness while filming - MSN

Hollyoaks star shares how she copes with painful illness while filming MSN

Published: Oct. 24, 2024, 9:50 p.m.

Read Full Article

Hope Medicine touts favourable mid-stage data for endometriosis therapy - FirstWord Pharma

Hope Medicine touts favourable mid-stage data for endometriosis therapy FirstWord Pharma

Published: Oct. 24, 2024, 9:31 p.m.

Read Full Article

Racial disparities in high-risk endometrial subtype diagnoses reported - Contemporary Obgyn

Racial disparities in high-risk endometrial subtype diagnoses reported Contemporary Obgyn

Published: Oct. 24, 2024, 6:26 p.m.

Read Full Article

Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer - OncLive

Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer OncLive

Published: Oct. 24, 2024, 3:55 p.m.

Read Full Article

Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer - Medscape

Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer Medscape

Published: Oct. 24, 2024, 1:44 p.m.

Read Full Article

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers BioSpace

Published: Oct. 24, 2024, 11:46 a.m.

Read Full Article

Approval From European Commission With Two New Indications in Gynecologic Cancers - businesswire.com

Approval From European Commission With Two New Indications in Gynecologic Cancers businesswire.com

Published: Oct. 24, 2024, 10:45 a.m.

Read Full Article

‘Small Increase’ in Breast Cancer With Levonorgestrel IUD? - Medscape

‘Small Increase’ in Breast Cancer With Levonorgestrel IUD? Medscape

Published: Oct. 24, 2024, 9:51 a.m.

Read Full Article

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - BioSpace

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation BioSpace

Published: Oct. 24, 2024, 5:36 a.m.

Read Full Article

Latest Articles

Feasibility of Percutaneous Radiofrequency Ablation for Abdominal Wall Endometriosis: A Prospective Pilot Study.

Hollyoaks star shares how she copes with painful illness while filming - MSN

Hope Medicine touts favourable mid-stage data for endometriosis therapy - FirstWord Pharma

Racial disparities in high-risk endometrial subtype diagnoses reported - Contemporary Obgyn

Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer - OncLive

Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer - Medscape

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace

Approval From European Commission With Two New Indications in Gynecologic Cancers - businesswire.com

‘Small Increase’ in Breast Cancer With Levonorgestrel IUD? - Medscape

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - BioSpace

Subscribe to Our Newsletter